Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years.

Shakespeare TP, Eggert E, Wood M, Westhuyzen J, Turnbull K, Rutherford N, Aherne N.

Radiother Oncol. 2019 Oct 23. pii: S0167-8140(19)33116-0. doi: 10.1016/j.radonc.2019.09.027. [Epub ahead of print]

PMID:
31668514
2.

A Low Iron Diet Protects from Steatohepatitis in a Mouse Model.

Salaye L, Bychkova I, Sink S, Kovalic AJ, Bharadwaj MS, Lorenzo F, Jain S, Harrison AV, Davis AT, Turnbull K, Meegalla NT, Lee SH, Cooksey R, Donati GL, Kavanagh K, Bonkovsky HL, McClain DA.

Nutrients. 2019 Sep 10;11(9). pii: E2172. doi: 10.3390/nu11092172.

3.

Intramolecular Interactions Dominate the Autoregulation of Escherichia coli Stringent Factor RelA.

Turnbull KJ, Dzhygyr I, Lindemose S, Hauryliuk V, Roghanian M.

Front Microbiol. 2019 Aug 27;10:1966. doi: 10.3389/fmicb.2019.01966. eCollection 2019.

4.

The E. coli HicB Antitoxin Contains a Structurally Stable Helix-Turn-Helix DNA Binding Domain.

Manav MC, Turnbull KJ, Jurėnas D, Garcia-Pino A, Gerdes K, Brodersen DE.

Structure. 2019 Nov 5;27(11):1675-1685.e3. doi: 10.1016/j.str.2019.08.008. Epub 2019 Sep 5.

PMID:
31495532
5.

How Lifestyle Factors Affect Cognitive and Executive Function and the Ability to Learn in Children.

Jirout J, LoCasale-Crouch J, Turnbull K, Gu Y, Cubides M, Garzione S, Evans TM, Weltman AL, Kranz S.

Nutrients. 2019 Aug 20;11(8). pii: E1953. doi: 10.3390/nu11081953. Review.

6.

A role for the Saccharomyces cerevisiae ABCF protein New1 in translation termination/recycling.

Kasari V, Pochopien AA, Margus T, Murina V, Turnbull K, Zhou Y, Nissan T, Graf M, Nováček J, Atkinson GC, Johansson MJO, Wilson DN, Hauryliuk V.

Nucleic Acids Res. 2019 Sep 19;47(16):8807-8820. doi: 10.1093/nar/gkz600.

PMID:
31299085
7.

Serine-Threonine Kinases Encoded by Split hipA Homologs Inhibit Tryptophanyl-tRNA Synthetase.

Vang Nielsen S, Turnbull KJ, Roghanian M, Bærentsen R, Semanjski M, Brodersen DE, Macek B, Gerdes K.

MBio. 2019 Jun 18;10(3). pii: e01138-19. doi: 10.1128/mBio.01138-19.

8.

Development of a symptom assessment in patients with myelofibrosis: qualitative study findings.

Mesa RA, Su Y, Woolfson A, Prchal JT, Turnbull K, Jabbour E, Scherber R, Shields AL, Krohe M, Ojo F, Pompilus F, Cappelleri JC, Harrison C.

Health Qual Life Outcomes. 2019 Apr 11;17(1):61. doi: 10.1186/s12955-019-1121-1.

9.

Identifying variant anatomy during ultrasound-guided regional anaesthesia: opportunities for clinical improvement.

Bowness J, Turnbull K, Taylor A, Halcrow J, Raju P, Mustafa A, Chisholm F, Varsou O, Grant C.

Br J Anaesth. 2019 May;122(5):e75-e77. doi: 10.1016/j.bja.2019.02.003. Epub 2019 Mar 4. No abstract available.

PMID:
30916020
10.

Laboratory acclimation to autumn-like conditions induces freeze tolerance in the spring field cricket Gryllus veletis (Orthoptera: Gryllidae).

Toxopeus J, McKinnon AH, Štětina T, Turnbull KF, Sinclair BJ.

J Insect Physiol. 2019 Feb - Mar;113:9-16. doi: 10.1016/j.jinsphys.2018.12.007. Epub 2018 Dec 21.

PMID:
30582905
11.

Identifying the emergence of the superficial peroneal nerve through deep fascia on ultrasound and by dissection: Implications for regional anesthesia in foot and ankle surgery.

Bowness J, Turnbull K, Taylor A, Halcrow J, Chisholm F, Grant C, Varsou O.

Clin Anat. 2019 Apr;32(3):390-395. doi: 10.1002/ca.23323. Epub 2019 Jan 7.

PMID:
30536834
12.

Morphological and functional properties distinguish the substance P and gastrin-releasing peptide subsets of excitatory interneuron in the spinal cord dorsal horn.

Dickie AC, Bell AM, Iwagaki N, Polgár E, Gutierrez-Mecinas M, Kelly R, Lyon H, Turnbull K, West SJ, Etlin A, Braz J, Watanabe M, Bennett DLH, Basbaum AI, Riddell JS, Todd AJ.

Pain. 2019 Feb;160(2):442-462. doi: 10.1097/j.pain.0000000000001406.

13.

Application of an incident taxonomy for radiation therapy: Analysis of five years of data from three integrated cancer centres.

Greenham S, Manley S, Turnbull K, Hoffmann M, Fonseca A, Westhuyzen J, Last A, Aherne NJ, Shakespeare TP.

Rep Pract Oncol Radiother. 2018 May-Jun;23(3):220-227. doi: 10.1016/j.rpor.2018.04.002. Epub 2018 May 10.

14.

An engineered minimal chromosomal passenger complex reveals a role for INCENP/Sli15 spindle association in chromosome biorientation.

Fink S, Turnbull K, Desai A, Campbell CS.

J Cell Biol. 2017 Apr 3;216(4):911-923. doi: 10.1083/jcb.201609123. Epub 2017 Mar 17.

15.

HicA toxin of Escherichia coli derepresses hicAB transcription to selectively produce HicB antitoxin.

Turnbull KJ, Gerdes K.

Mol Microbiol. 2017 Jun;104(5):781-792. doi: 10.1111/mmi.13662. Epub 2017 Mar 21.

16.

Predator exposure-induced immunosuppression: trade-off, immune redistribution or immune reconfiguration?

Adamo SA, Easy RH, Kovalko I, MacDonald J, McKeen A, Swanburg T, Turnbull KF, Reeve C.

J Exp Biol. 2017 Mar 1;220(Pt 5):868-875. doi: 10.1242/jeb.153320. Epub 2016 Dec 23.

17.

Tangential intensity modulated radiation therapy (IMRT) to the intact breast.

Dean J, Hansen CJ, Westhuyzen J, Waller B, Turnbull K, Wood M, Last A.

J Med Radiat Sci. 2016 Dec;63(4):217-223. doi: 10.1002/jmrs.185. Epub 2016 Jul 18.

18.

Prostate intensity-modulated radiotherapy planning in seven mouse clicks: Development of a class solution for cancer.

Wood M, Fonseca A, Sampson D, Kovendy A, Westhuyzen J, Shakespeare T, Turnbull K.

Rep Pract Oncol Radiother. 2016 Nov-Dec;21(6):567-570. Epub 2016 Sep 30.

19.

The parasitic wasp Cotesia congregata uses multiple mechanisms to control host (Manduca sexta) behaviour.

Adamo SA, Kovalko I, Turnbull KF, Easy RH, Miles CI.

J Exp Biol. 2016 Dec 1;219(Pt 23):3750-3758. Epub 2016 Sep 15.

20.

Risk factors for requiring intravenous antibiotic therapy in hospital and 30-day readmission for exacerbations of bronchiectasis.

Velu PP, Bedi P, Turnbull K, Hill AT.

QJM. 2016 Nov;109(11):723-729. Epub 2016 Apr 13.

PMID:
27081209
21.

Reconfiguration of the immune system network during food limitation in the caterpillar Manduca sexta.

Adamo SA, Davies G, Easy R, Kovalko I, Turnbull KF.

J Exp Biol. 2016 Mar;219(Pt 5):706-18. doi: 10.1242/jeb.132936. Epub 2016 Jan 8.

22.

Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.

Brümmendorf TH, Cortes JE, Khoury HJ, Kantarjian HM, Kim DW, Schafhausen P, Conlan MG, Shapiro M, Turnbull K, Leip E, Gambacorti-Passerini C, Lipton JH.

Br J Haematol. 2016 Jan;172(1):97-110. doi: 10.1111/bjh.13801. Epub 2015 Nov 4.

23.

Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.

Gambacorti-Passerini C, Kantarjian HM, Kim DW, Khoury HJ, Turkina AG, Brümmendorf TH, Matczak E, Bardy-Bouxin N, Shapiro M, Turnbull K, Leip E, Cortes JE.

Am J Hematol. 2015 Sep;90(9):755-68. doi: 10.1002/ajh.24034. Epub 2015 Jun 1.

24.

Crystal structure of 4-(2-bromo-prop-ion-yl)-3-phenyl-sydnone.

Grossie D, Harrison L, Turnbull K.

Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 18;70(Pt 11):o1165-6. doi: 10.1107/S1600536814022260. eCollection 2014 Nov 1.

25.

A prospective cohort study of the use of domiciliary intravenous antibiotics in bronchiectasis.

Bedi P, Sidhu MK, Donaldson LS, Chalmers JD, Smith MP, Turnbull K, Pentland JL, Scott J, Hill AT.

NPJ Prim Care Respir Med. 2014 Oct 23;24:14090. doi: 10.1038/npjpcrm.2014.90.

26.

Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study.

Isakoff SJ, Wang D, Campone M, Calles A, Leip E, Turnbull K, Bardy-Bouxin N, Duvillié L, Calvo E.

Br J Cancer. 2014 Nov 25;111(11):2058-66. doi: 10.1038/bjc.2014.508. Epub 2014 Oct 7.

27.

Prospective evaluation of unmet needs of rural and aboriginal cancer survivors in Northern British Columbia.

Olson RA, Howard F, Turnbull K, Munroe D, Zirul C, Manji R, Tobin P, Ward A.

Curr Oncol. 2014 Apr;21(2):e179-85. doi: 10.3747/co.21.1729.

28.

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.

Gambacorti-Passerini C, Brümmendorf TH, Kim DW, Turkina AG, Masszi T, Assouline S, Durrant S, Kantarjian HM, Khoury HJ, Zaritskey A, Shen ZX, Jin J, Vellenga E, Pasquini R, Mathews V, Cervantes F, Besson N, Turnbull K, Leip E, Kelly V, Cortes JE.

Am J Hematol. 2014 Jul;89(7):732-42. doi: 10.1002/ajh.23728. Epub 2014 Apr 28.

29.

Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.

Moy B, Neven P, Lebrun F, Bellet M, Xu B, Sarosiek T, Chow L, Goss P, Zacharchuk C, Leip E, Turnbull K, Bardy-Bouxin N, Duvillié L, Láng I.

Oncologist. 2014 Apr;19(4):348-9. doi: 10.1634/theoncologist.2014-0021. Epub 2014 Mar 27.

30.

Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.

Moy B, Neven P, Lebrun F, Bellet M, Xu B, Sarosiek T, Chow L, Goss P, Zacharchuk C, Leip E, Turnbull K, Bardy-Bouxin N, Duvillié L, Láng I.

Oncologist. 2014 Apr;19(4):346-7. doi: 10.1634/theoncologist.2014-0022. Epub 2014 Mar 27.

31.

Access to medical and supportive care for rural and remote cancer survivors in northern British Columbia.

Fuchsia Howard A, Smillie K, Turnbull K, Zirul C, Munroe D, Ward A, Tobin P, Kazanjian A, Olson R.

J Rural Health. 2014 Summer;30(3):311-21. doi: 10.1111/jrh.12064. Epub 2014 Feb 1.

PMID:
24483272
32.

4-Acetyl-3-[2-(eth-oxy-carbon-yl)phen-yl]sydnone.

Grossie D, Harrison L, Turnbull K.

Acta Crystallogr Sect E Struct Rep Online. 2013 Oct 19;69(Pt 11):o1662. doi: 10.1107/S1600536813027207. eCollection 2013 Oct 19.

33.

Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors.

Kantarjian HM, Cortes JE, Kim DW, Khoury HJ, Brümmendorf TH, Porkka K, Martinelli G, Durrant S, Leip E, Kelly V, Turnbull K, Besson N, Gambacorti-Passerini C.

Blood. 2014 Feb 27;123(9):1309-18. doi: 10.1182/blood-2013-07-513937. Epub 2013 Dec 17. Erratum in: Blood. 2014 Aug 7;124(6):981.

34.

Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.

Gandhi L, Bahleda R, Tolaney SM, Kwak EL, Cleary JM, Pandya SS, Hollebecque A, Abbas R, Ananthakrishnan R, Berkenblit A, Krygowski M, Liang Y, Turnbull KW, Shapiro GI, Soria JC.

J Clin Oncol. 2014 Jan 10;32(2):68-75. doi: 10.1200/JCO.2012.47.2787. Epub 2013 Dec 9.

PMID:
24323026
35.

3-{5-Bromo-2-[(tri-phenyl-phosphanyl-idene)amino]-phen-yl}-4,5-di-hydro-1,2,3-oxa-diazol-3-ylium-5-olate.

Grossie D, Harrison L, Turnbull K.

Acta Crystallogr Sect E Struct Rep Online. 2013 Jul 3;69(Pt 8):o1196. doi: 10.1107/S1600536813017765. eCollection 2013.

36.
37.

Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis.

Mandal P, Sidhu MK, Donaldson LS, Chalmers JD, Smith MP, Turnbull K, Scott J, Hill AT.

QJM. 2013 Jan;106(1):27-33. doi: 10.1093/qjmed/hcs173. Epub 2012 Sep 27.

PMID:
23019590
38.

A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.

Mandal P, Sidhu MK, Kope L, Pollock W, Stevenson LM, Pentland JL, Turnbull K, Mac Quarrie S, Hill AT.

Respir Med. 2012 Dec;106(12):1647-54. doi: 10.1016/j.rmed.2012.08.004. Epub 2012 Sep 1.

39.

Use of specialist knowledge and experience to manage patients with mixed aetiology leg ulcers.

Neill K, Turnbull K.

J Wound Care. 2012 Apr;21(4):168, 170, 172-4.

PMID:
22584674
40.

Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.

Daud AI, Krishnamurthi SS, Saleh MN, Gitlitz BJ, Borad MJ, Gold PJ, Chiorean EG, Springett GM, Abbas R, Agarwal S, Bardy-Bouxin N, Hsyu PH, Leip E, Turnbull K, Zacharchuk C, Messersmith WA.

Clin Cancer Res. 2012 Feb 15;18(4):1092-100. doi: 10.1158/1078-0432.CCR-11-2378. Epub 2011 Dec 16.

41.

Molecular diversity of methanogens in fecal samples from Bactrian camels (Camelus bactrianus) at two zoos.

Turnbull KL, Smith RP, St-Pierre B, Wright AD.

Res Vet Sci. 2012 Aug;93(1):246-9. doi: 10.1016/j.rvsc.2011.08.013. Epub 2011 Sep 13.

PMID:
21917280
42.

The impact of teacher responsivity education on preschoolers' language and literacy skills.

Cabell SQ, Justice LM, Piasta SB, Curenton SM, Wiggins A, Turnbull KP, Petscher Y.

Am J Speech Lang Pathol. 2011 Nov;20(4):315-30. doi: 10.1044/1058-0360(2011/10-0104). Epub 2011 Aug 19.

PMID:
21856968
43.

Seasonal trends in adolescent pregnancy conception rates.

Turnbull K, Nguyen LN, Jamieson MA, Palerme S.

J Pediatr Adolesc Gynecol. 2011 Oct;24(5):291-3. doi: 10.1016/j.jpag.2011.04.005. Epub 2011 Jun 29.

PMID:
21715196
44.

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.

Campone M, Bondarenko I, Brincat S, Hotko Y, Munster PN, Chmielowska E, Fumoleau P, Ward R, Bardy-Bouxin N, Leip E, Turnbull K, Zacharchuk C, Epstein RJ.

Ann Oncol. 2012 Mar;23(3):610-7. doi: 10.1093/annonc/mdr261. Epub 2011 Jun 23.

PMID:
21700731
45.

Mastering inflectional suffixes: a longitudinal study of beginning writers' spellings*.

Turnbull K, Deacon SH, Kay-Raining Bird E.

J Child Lang. 2011 Jun;38(3):533-53. doi: 10.1017/S030500091000022X. Epub 2010 Aug 26.

PMID:
20738892
46.

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer.

Burstein HJ, Sun Y, Dirix LY, Jiang Z, Paridaens R, Tan AR, Awada A, Ranade A, Jiao S, Schwartz G, Abbas R, Powell C, Turnbull K, Vermette J, Zacharchuk C, Badwe R.

J Clin Oncol. 2010 Mar 10;28(8):1301-7. doi: 10.1200/JCO.2009.25.8707. Epub 2010 Feb 8.

PMID:
20142587
47.

Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis.

Murray MP, Pentland JL, Turnbull K, MacQuarrie S, Hill AT.

Eur Respir J. 2009 Aug;34(2):361-4. doi: 10.1183/09031936.00163208.

48.

Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis.

Murray MP, Turnbull K, MacQuarrie S, Pentland JL, Hill AT.

Eur Respir J. 2009 Jul;34(1):125-31. doi: 10.1183/09031936.00160508. Epub 2009 Feb 5.

49.

3-(2-Acetamido-phen-yl)sydnone.

Grossie DA, Turnbull K, Felix-Balderrama S, Raghavapuram S.

Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 21;65(Pt 3):o554-5. doi: 10.1107/S1600536809005066.

50.

Assessing response to treatment of exacerbations of bronchiectasis in adults.

Murray MP, Turnbull K, Macquarrie S, Hill AT.

Eur Respir J. 2009 Feb;33(2):312-8. doi: 10.1183/09031936.00122508. Epub 2008 Oct 1.

Supplemental Content

Loading ...
Support Center